FY2024 Earnings Forecast for Albemarle Issued By Scotiabank

Albemarle Co. (NYSE:ALBFree Report) – Stock analysts at Scotiabank decreased their FY2024 earnings per share estimates for Albemarle in a research note issued on Monday, November 11th. Scotiabank analyst B. Isaacson now expects that the specialty chemicals company will post earnings of ($2.11) per share for the year, down from their prior estimate of $3.10. Scotiabank currently has a “Sector Perform” rating and a $85.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($1.10) per share. Scotiabank also issued estimates for Albemarle’s FY2025 earnings at $2.74 EPS.

A number of other equities research analysts have also commented on the company. Robert W. Baird dropped their target price on Albemarle from $85.00 to $79.00 and set a “neutral” rating on the stock in a research report on Friday, October 25th. Evercore ISI reduced their price objective on Albemarle from $190.00 to $170.00 and set an “outperform” rating for the company in a research note on Wednesday, August 28th. Berenberg Bank downgraded Albemarle from a “buy” rating to a “hold” rating and reduced their price objective for the company from $160.00 to $83.00 in a research note on Wednesday, July 31st. Wells Fargo & Company increased their price objective on Albemarle from $100.00 to $110.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 8th. Finally, Oppenheimer dropped their target price on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $114.47.

View Our Latest Research Report on ALB

Albemarle Price Performance

Shares of NYSE ALB opened at $103.53 on Thursday. The business’s 50 day moving average price is $95.52 and its 200 day moving average price is $100.06. The firm has a market cap of $12.17 billion, a P/E ratio of -6.18 and a beta of 1.55. Albemarle has a 52 week low of $71.97 and a 52 week high of $153.54. The company has a quick ratio of 1.58, a current ratio of 2.44 and a debt-to-equity ratio of 0.43.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, December 13th will be given a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Friday, December 13th. Albemarle’s dividend payout ratio (DPR) is presently -9.67%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of ALB. First Community Trust NA purchased a new stake in Albemarle during the second quarter worth $25,000. Quarry LP lifted its position in shares of Albemarle by 1,400.0% in the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 252 shares in the last quarter. CVA Family Office LLC lifted its position in shares of Albemarle by 610.0% in the second quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 244 shares in the last quarter. Eastern Bank purchased a new position in Albemarle during the third quarter worth about $31,000. Finally, Cromwell Holdings LLC lifted its position in Albemarle by 61.9% during the third quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company’s stock worth $37,000 after buying an additional 148 shares during the period. 92.87% of the stock is currently owned by hedge funds and other institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Further Reading

Earnings History and Estimates for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.